Shui, X. and Jiang, Y. and Peng, C. and Wang, J. and Cao, Q. and Jia, Q. and Liu, S. and Li, J.
Abstract
The Patient Acceptable Symptom State (PASS), a patient-reported outcome measure, has demonstrated correlations with disease severity in various conditions, including psoriasis and scleroderma. However, the clinical relevance of PASS in the context of chronic spontaneous urticaria (CSU) remains to be fully elucidated.